 Home > Popular Keywords > Keyword List T > tenofovir taf

tenofovir taf

Dig into the news of tenofovir taf. Discover information that you didn't know about tenofovir taf on echemi.com.

Related Tags

tenofovir alafenamide fumarate

tenofovir price news info

Hepatitis B super heavy news! Vemlidy (TAF), the safest new drug in Gilead's history, has been approved by China

 Time of Update: 2021-02-14

U.S. pharmaceutical giant Gilead recently announced that the antiviral drug Vemlidy (tenofovir alafenamide, TAF, tinofovir phenolamine fumaric acid) has been approved by China's State Drug Administration (NMPA) as a daily drug for the treatment
Clinical approval for tenofovir dipivoxil fumarate, a new drug of Anke in the treatment of AIDS

 Time of Update: 2020-04-03

Tenofovir fumarate dipivoxil (tablets) is a nucleotide reverse transcriptase inhibitor, which is mainly used in the treatment of AIDS, hepatitis B and other diseases
Tenofovir dipivoxil fumarate (raw material + tablet), a Class 3 hepatitis B drug of Anke biology, will obtain clinical approval

 Time of Update: 2020-04-03

According to CFDA, tenofovir fumarate dipivoxil tablets declared for production by Anhui Baker biopharmaceutical Co., Ltd. have been in the state of "approval".
Is the second upgrade of tenofovir a strategy or a real improved drug?

 Time of Update: 2019-09-18

Nearly 90 million people with HBV infection define China as a big country of hepatitis B; the huge number of HBV infection has led to nearly half of the world's liver cancer
12.16 million yuan invested in R & D! Tenofovir dipivoxil hesco fumarate tablets approved

 Time of Update: 2019-04-10

On April 10, hisic announced that its wholly-owned subsidiary Sichuan hisic Pharmaceutical Co., Ltd. had recently received the approval document for drug registration of tenofovir dipivoxil fumarate tablets approved and issued by the State Drug Administration.
[annual inventory] Research Progress of tenofovir esters in the treatment of hepatitis B

 Time of Update: 2018-12-29

The application of tenofovir fumarate (TDF) in the field of hepatitis B treatment has always been of great concern

In November 2018, the imported propofol tenofovir
[annual inventory] Research Progress of tenofovir esters in the treatment of hepatitis B

 Time of Update: 2018-12-29

The application of tenofovir fumarate (TDF) in the field of hepatitis B treatment has always been of great concern

In November 2018, the imported propofol tenofovir
Weigh! TAF, the best new hepatitis B drug in history, has been approved for listing in China

 Time of Update: 2018-11-16

On November 14, the new drug application (jxhl1700186) of Gilead's new hepatitis B drug, "fospropofol tablets" (TAF), was approved by the National Drug Administration (nmpa
[Yao Kejun] Zhengda Tianqing TAF has applied for listing! Howson's first lung cancer drug is coming

 Time of Update: 2018-10-29

Highlights: 1

Xinlitai 60mg tegrilol tablet shows "hair piece"; 2

Haosen's first lung cancer drug, alfatinib maleate tablet, shows "hair piece"; 3
When is the first-line drug TAF of hepatitis B listed in China? @State Drug Administration

 Time of Update: 2018-05-25

At present, according to European EASL guidelines and American AASLD guidelines, the first-line oral antiviral therapy for chronic hepatitis B includes entecavir, TDF and TAF.
Qilu pharmaceutical won 150 million orders from CDC for tenofovir

 Time of Update: 2017-12-18

Purchasing agency: China Technology International Tendering Co., Ltd. address of the purchasing agency: room 1101, general technology building, No.90, middle Xisanhuan Road, Fengtai District, Beijing contact information of the purchasing agency: 63348421 4.
The first variety that passed the consistency evaluation was born: tenofovir fumarate dipivoxil tablets

 Time of Update: 2017-12-06

Source: magic cube data 2017-12-06 China biopharmaceutical Co., Ltd. announced on December 5 that the drug "tenofovir dipivoxil fumarate tablets" developed by the group has obtained the drug registration approval issued by CFDA for the treatment of chronic hepatitis B.
Talk about tenofovir again! Pay homage to the medical practitioners who witnessed the changes of the industry

 Time of Update: 2017-06-05

The earliest application time of TDF of Zhengda Tianqing, Chengdu Beite, guangshengtang, Qilu pharmaceutical and other enterprises was between 2008 and 2014, so there were different registration classifications.
Tenofovir's market competitiveness of hepatitis B in China has been greatly improved

 Time of Update: 2017-05-25

[China Pharmaceutical network enterprise news] tenofovir is an oral nucleoside antiviral drug developed by Gilead, which was listed in the United States in 2001.
Failure of foreign companies in patent invalidation cases of tenofovir will usher in the era of parity

 Time of Update: 2017-05-10

Source: People's daily 2017-05-10 in March last year, a patent invalidation case involving tens of millions of hepatitis B and AIDS patients nationwide was appealed to Beijing Higher People's court.
The 96 week treatment result of the new heavy weight hepatitis B drug TAF announced: still strong and safer

 Time of Update: 2017-04-21

Source: Sina medicine 2017-04-21 April 20, Gilead announced the 96 week efficacy and safety results of two ongoing phase III studies of hepatitis B new drug vemlidy (TAF, tenofovir
Tenofovir's price has been greatly reduced. Is it far for the latest hepatitis C drugs to be introduced into China?

 Time of Update: 2016-08-03

Source: after the price negotiation of nai500 2016-08-02, the price of tenofovir, a hepatitis B drug, has been greatly reduced in China, which may pave the way for cutting-edge
The patent of tenofovir was judged invalid and domestic enterprises seized the market of hepatitis B drugs

 Time of Update: 2013-08-12

Recently, the National Patent Reexamination Board ruled that the patent of tenofovir, a drug for hepatitis B and AIDS treatment by Gilead science company, was all invalid
The patent of tenofovir was judged invalid, and the pharmaceutical companies seized the market of hepatitis B drugs

 Time of Update: 2013-07-18

Recently, the National Patent Reexamination Board ruled that the patents of Gilead science company for the treatment of hepatitis B and AIDS drugs tenofovir were all invalid.

Related Keywords

taf mek novartis

Hot Products

Citric Acid Monohydrate

CAS No.: 5949-29-1

Food Grade

Propyl Acetate Industrial Grade

CAS No.: 109-60-4

Industrial Grade

Caustic soda Flakes 99%

CAS No.: 1310-73-2

Tech Grade

Hot Tags

toy conveyor belt(90)

tianeptine supply(44)

tecfidera start form(52)

teflon flu(98)

tsg consulting(9)

What's trending

Top Keywords

top 100 companies in the us

The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

tenofovir taf

tenofovir alafenamide

tenofovir news info

tenofovir alafenamide fumarate

tenofovir price news info

mek taf

taf mexico

tafs reviews

taf protein

taf testing

aberdeen taf

bictegravir taf ftc

taf mek novartis